Forest Pharmaceuticals Inc recalls Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-caps
Recalled February 12, 2014 · FDA recall D-1064-2014 · Forest Pharmaceuticals
Hazard
Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing. · FDA Class III
Units
3,950 packs
Sold at
Nationwide and Puerto Rico.
Description
Failed Dissolution Specifications: Three lots of product being recalled having failed stability dissolution testing.
Product
Namenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packaged in 28-capsule, 4 week, titration pack,Rx only, Forest Pharmaceuticals Inc., St. Louis, MO 63045 NDC 0456-3400-29.
Manufacturer(s)
Forest Pharmaceuticals Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →